VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

Teladoc Health Executive Compensation (FY25)

TDOC · New York, NY · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Charles Divita, III
Latest say-on-pay support
=
May 21, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The Teladoc Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
Data as of November 3, 2026Latest filing (8-K): May 21, 2026
14 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Teladoc Health brief$500Get the executive brief
Velarion Intel, one year, every company
301 figures on this page: 295 cited to the filing that reported them, 6 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Charles Divita, III: $16,061,267 → $11,202,996 (30.2% lower)
Say-on-pay support: 73.4% → 88.8% (15.4 points higher)
CEO pay ratio: 201:1 → 127.6:1 (36.5% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Teladoc Health's chief executive and what were they paid?
Charles Divita, III was paid $11,202,996 in total compensation as Chief Executive Officer for fiscal 2025. Compared with the $16,061,267 reported for fiscal 2024, Divita, III's total was 30.2% lower.
What was Teladoc Health's say-on-pay result?
Shareholders supported the say-on-pay proposal with 88.8% of votes cast for or against in favor at the meeting held May 21, 2026 for fiscal 2025.
Which companies are in Teladoc Health's peer group?
Companies named in the disclosed peer group include Agilon Health, Inc., Alignment Healthcare, Inc., AMN Healthcare Services, Inc., Astrana Health, Inc. and Aveanna Healthcare Holdings Inc., among others.
What is Teladoc Health's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 127.6:1, against median employee compensation of $87,811.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jason Gorevic
Chief Executive Officer
◇—◇—◇—◇◇
Mala Murthy
Chief Financial Officer
◇—◇◇◇—◇◇
Claus Jensen
Chief Innovation Officer
◇—◇◇◇—◇◇
Laizer Kornwasser
President, Enterprise Growth and Global Markets
◇◇◇—◇——◇
Michael Waters
Chief Operating Officer
◇◇◇—◇——◇
Adam Vandervoort
Chief legal officer and secretary
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jason Gorevic
Former chief executive officer
Departed during or after this year
◇—◇—◇—◇◇
Mala Murthy
Interim chief executive officer and principal financial officer
Served on an interim basis
◇—◇—◇—◇◇
Laizer Kornwasser
President, enterprise growth and global markets
◇—◇—◇——◇
Michael Waters
Chief operating officer
◇—◇—◇—◇◇
Adam Vandervoort
Chief legal officer and secretary
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Charles Divita, III
Chief Executive Officer
◇—◇—◇—◇◇
Jason Gorevic
Former Chief Executive Officer
Departed during or after this year
◇—◇—◇—◇◇
Mala Murthy
Chief Financial Officer
◇—◇—◇—◇◇
Michael Waters
Former Chief Operating Officer
Departed during or after this year
◇—◇—◇—◇◇
Laizer Kornwasser
Former President, Enterprise Growth and Global Markets
Departed during or after this year
◇—◇———◇◇
Carlos Nueno
President, International
◇◇◇—◇—◇◇
Adam C. Vandervoort
Chief Legal Officer and Secretary
◇◇◇—◇—◇◇
Kelly Bliss
President, U.S. Group Health
◇◇◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Charles Divita, III
Chief Executive Officer
◇—◇—◇—◇◇
Mala Murthy
Former Chief Financial Officer
Departed during or after this year
◇—◇———◇◇
Carlos Nueno
President, International
◇—◇—◇—◇◇
Kelly Bliss
President, U.S. Group Health
◇—◇—◇—◇◇
Adam Vandervoort
Chief Legal Officer and Secretary
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Adam C. VandervoortPSU◇—◇—◇—◇
Adam C. VandervoortRSU◇——◇——◇
Carlos NuenoPSU◇—◇—◇—◇
Carlos NuenoRSU◇——◇——◇
Charles Divita IIIPSU◇—◇—◇—◇
Charles Divita IIIRSU◇——◇——◇
Kelly BlissRSU◇——◇——◇
Kelly BlissPSU◇—◇—◇—◇
Mala MurthyRSU◇——◇——◇
Mala MurthyPSU◇—◇—◇—◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Charles DivitaRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Adam VandervoortRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Kelly BlissRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Carlos NuenoRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Kelly Bliss
President, U.S. Group Health · Terms as described in the company’s compensation discussion · dated July 14, 2017
Severance multiple◇
Severance base◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Non-compete period◇
Non-solicit period◇
Clawback◇
Adam Vandervoort
Amended agreement
Severance multiple◇
Severance base◇
Benefits continuation on change in control◇
Benefits continuation◇
Carlos Nueno
President, International · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance base◇
Benefits continuation on change in control◇
Benefits continuation◇
Charles Divita, III
Chief Executive Officer · Employment agreement
Severance multiple◇
Severance base◇
Mala Murthy
Former Chief Financial Officer · Amended agreement
Severance multiple◇
Severance base◇
Benefits continuation on change in control◇
Benefits continuation◇
Non-compete period◇
Non-solicit period◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
David B. Snow, Jr
◇◇————◇
Kenneth H. Paulus
Board chair
◇◇————◇
J. Eric Evans
◇◇————◇
David L. Shedlarz
◇◇————◇
Thomas G. McKinley
◇◇————◇
Mark Douglas Smith, M.D., MBA
◇◇————◇
Catherine A. Jacobson
◇◇————◇
Sandra L. Fenwick
◇◇————◇
Charles Divita, III, Susan R. Salka and Michael S. Smith served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Agilon Health, Inc. AGL
  • Alignment Healthcare, Inc. ALHC
  • AMN Healthcare Services, Inc. AMN
  • Astrana Health, Inc. ASTH
  • Aveanna Healthcare Holdings Inc. AVAH
  • Clover Health Investments, Corp. CLOV
  • DocuSign, Inc. DOCU
  • Dropbox, Inc. DBX
  • Euronet Worldwide, Inc. EEFT
  • Evolent Health, Inc. EVH
  • Maximus Inc. MMS
  • Medpace, Inc. MEDP
  • Nutanix, Inc. NTNX
  • OpenText Corporation symbol not shown
  • Pediatrix Medical Group, Inc. MD
  • Premier Inc. PINC
  • Privia Health Group, Inc. PRVA
  • RingCentral, Inc. RNG
  • Twilio Inc. TWLO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 21, 2026=◇◇◇
2024May 22, 2025=◇◇◇
2023May 23, 2024=◇◇◇
2022May 25, 2023=◇◇◇
2021May 26, 2022=◇◇◇
2020May 17, 2021=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Charles Divita, III (Chief Executive Officer), FY2025 total compensation $11,202,996 (base salary $800,000) [exec_comp, SEC accession 0001477449-26-000020, filed 2026-04-07]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Teladoc Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Teladoc Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Teladoc Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Teladoc Health's disclosed peer group is defensible, who names Teladoc Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
301 figures on this page: 295 cited to the filing that reported them, 6 calculated from figures it prints.
295 cited to the filing
6 calculated from the filing

Documents cited

  1. 0001477449-26-000030
    Proposal 2 — Advisory Vote Approving the Compensation of the Company’s Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to the Company’s n
  2. 0001477449-26-000020
    2025 Director compensation table · 2025 Grants of Plan-Based Awards Table · 2025 Outstanding equity awards at fiscal year-end table · 2025 Summary Compensation Table · and 3 more sections
  4. 0001477449-25-000063
    Proposal 2 — Advisory Vote Approving the Compensation of the Company’s Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to the Company’s n
  5. 0001477449-25-000040
    2024 Summary compensation table
  6. 0001477449-25-000005
    EX-10.45
  7. 0001477449-24-000122
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001477449-24-000090
    Summary Compensation Table
  11. 0001104659-23-066013
  12. 0001104659-23-044031
    2022 SUMMARY COMPENSATION TABLE
  13. 0001104659-22-067619
  14. 0001104659-21-068841
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Teladoc Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/TDOC (accessed 2026).
Short form: data: Velarion

The Teladoc Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Teladoc Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Teladoc Health discloses

The companies named in TDOC's own disclosed peer group.

Agilon Health, Inc.Alignment Healthcare, Inc.AMN Healthcare Services, Inc.Astrana Health, Inc.Aveanna Healthcare Holdings Inc.Clover Health Investments, Corp.DocuSign, Inc.Dropbox, Inc.Euronet Worldwide, Inc.Evolent Health, Inc.Maximus Inc.Medpace, Inc.Nutanix, Inc.Pediatrix Medical Group, Inc.Premier Inc.Privia Health Group, Inc.RingCentral, Inc.Twilio Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy